Civic Intelligence

Frontiers in Bioscience Inc.

990 • Fiscal year 2022 • EIN 59-3432665

Jan 01, 2022 to Dec 31, 2022 • Filed on May 03, 2023

Organization ProfileWWW.BIOSCIENCE.ORG
20 Sunset CoveNewport Coast, CA 92657

(949) 715-8286

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

24th percentile

0.02x

Higher debt load relative to assets than 24% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Liabilities / Revenue

87th percentile

1.35x

Higher debt load relative to revenue than 87% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Net Margin

3rd percentile

-109%

Higher net margin than 3% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Top Officer Pay

22nd percentile

$0

Higher top officer pay than 22% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Asset Growth

44th percentile

-1.0%

Faster asset growth than 44% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Revenue Growth

6th percentile

-54%

Faster revenue growth than 6% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets24th percentile

Assets

Down

$9,068,473

Down $195,195 (-2.1%) from 2021

Net Assets

Down

$8,892,603

Down $183,545 (-2.0%) from 2021

Liabilities

Down

$175,870

Down $11,650 (-6.2%) from 2021

Revenue And Expenses
Liabilities / Revenue87th percentileNet Margin3rd percentile

Revenue

Down

$130,196

Down $157,125 (-55%) from 2021

Expenses

Up

$272,103

Up $32,744 (+14%) from 2021

Net Income

Down

-$141,907

Down $189,869 (-396%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth44th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2022

Assets$9,068,473
Liabilities$175,870
Net Assets$8,892,603
Open 2022 Filing

Operations Trend

Revenue Growth6th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2022

Revenue$130,196
Expenses$272,103
Net Income-$141,907
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
May 3, 2023
Return Version
2022v5.0
Gross Receipts
$331,642
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$5,876,274$5,774,036▼ $102,238
Savings and Temporary Cash Investments$2,364,955$3,006,672▲ $641,717
Cash and Non-Interest-Bearing Accounts$980,439$219,428▼ $761,011
Loans From Officers Directors$154,516$154,516→ $0
Investments in Publicly Traded Securities-$68,337-
Total Assets$9,221,668$9,068,473▼ $153,195
Liabilities
Other Liabilities$33,004$21,354▼ $11,650
Total Liabilities$187,520$175,870▼ $11,650
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$9,034,148$8,892,603▼ $141,545
Total Net Assets Fund Balance$9,034,148$8,892,603▼ $141,545
Total Liabilities and Net Assets / Fund Balance$9,221,668$9,068,473▼ $153,195

Asset Categories

AssetBook ValueDepreciationBasis
Buildings$2,519,334$769,271$3,288,605
Land$3,229,805-$3,229,805
Other Land Buildings$24,897$362,932$387,829
Compensation and Service Providers
Top Officer Pay22nd percentile

Board Members and Trustees

NameTitle
Siamak Tabibzadeh MdCEO
Shila RoofimCFO
Forough SooferianSec
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$145,199
Investment Income
$24,026
Other Revenue
$-39,029
Change in Net Assets
$-141,907
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$150,463
Other Expenses$121,640
Total Fundraising Expense$9,580
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Comp Disqual Persons$70,400$8,800$8,800$88,000
Other Salaries and Wages$50,000--$50,000
Depreciation Depletion$47,688--$47,688
Payroll Taxes$10,903$780$780$12,463
All Other Expenses$9,489$2,512-$12,001
Fees for Services Accounting$3,775--$3,775
Other Expenses$3,594$15,781-$3,594
Insurance$2,771--$2,771
Travel$1,271--$1,271
Office Expenses$117$46-$163
Total Functional Expenses$214,158$48,365$9,580$272,103
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$154,516$154,516→ $0
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Tenant Deposits$16,890
Credit Card/ Payroll Taxes$4,464
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Backup withholding compliance
No
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“No review was or will be conducted.”

Form 990, Page 6, Part VI, Line 19

“No documents available to the public”

Filing and Contact Details

Filer

Filer Name
Frontiers in Bioscience
EIN
59-3432665
Phone
9497158286
Address
20 SUNSET COVE, NEWPORT COAST, CA 92657

Signing Officer

Name
Siamak Tabibzadeh Md
Title
CEO
Phone
9497158286
Signed
2023-05-03
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Siamak Tabibzadeh Md
Voting Board Members
3
Independent Board Members
0
Employees
2

Preparer

Firm
Lgh Consulting Inc
Address
585 S STATE COLLEGE BLVD, ANAHEIM, CA 92806-4222
Preparer
George Hukriede
Phone
7148089170
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

“Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.”

Form 990

“See attachment november 20, 2022 part iv, line 63, loans from officers, director and employee on november 20, 2002, frontiers in bioscience, inc. Purchased for investment purposes only residential real estate located at 67 parkview drive, searingtown, new york. In connection with the organization's purchase of said real estate, frontiers in bioscience inc., incurred a mortgage payable with the presiden and founder, siamak tabibzadeh, md, in the amount of 145,000 lender's name: siamak tabibzadeh, md original amount of note: 154,000 balance due: 145,555 date of note: november 20, 2002 maturity date: open, see below repayment terms: principal and accrued interest due upon sale of property interest rete: rate of 4.5% per annum, principal and interest due upon sale of property or at such time as the board of director determines that there are sufficient operating funds to retire the obiligation security priovided by the borrower: mortgage note secured by real estate located at 67 parkview drive, searingtown, ny 11507 purpose of the loan: to be able to purchase real estate at below fair market value to see in no longer than two operating cycles in order to obtain sufficient funding to endow a full time medical researcher and editor. Interst calcuation original amount of principal: 154,000 from to interest amount (rate, 4.5%) - principal + interest nov 20, 2002 154,000 nov 20, 2002 nov 20, 2003 6,930 - 160,930 - 15,375 removed principal & interest leaving 145,555 nov 20, 2003 nov 20, 2004 6,549 - 152,104 nov 20, 2004 nov 20, 2005 6,844 - 158,948 nov 20, 2005 nov 20, 2006 7,152 - 166,100 nov 20, 2006 nov 20, 2007 7,474 - 173,574 nov 20, 2007 nov 20, 2008 7,810 - 181,384 nov 20, 2008 nov 20, 2009 8,162 - 189,546 nov 20, 2009 nov 20, 2010 8,529 - 198,075 nov 20, 2010 nov 20, 2011 8,913 - 206,988 nov 20, 2011 nov 20, 2012 9,314 - 216,302 nov 20, 2012 nov 20, 2013 9,733 - 226,035 nov 20, 2013 nov 20, 2014 10,171 - 236,206 nov 20, 2014 nov 20, 2015 10,629 - 257,942 nov 20, 2015 nov 20, 2016 11,107 - 246,835 nov 20, 2016 nov 20, 2017 11,607 - 269,549 principal paid 269,549-145,555=123,994 nov 20, 2017 nov 20, 2018 5,579 - 129,573 nov 20, 2018 nov 20, 2019 5,830 - 135,403 nov 20, 2019 nov 20, 2020 6,093 - 141,496 nov 20, 2020 nov 20, 2021 6,367 - 147,863 nov 20, 2021 nov 20, 2022 6,653 - 154.516”

Form 990, Part XI

“Adjustment to beginning of value of investments -14160”

Raw XML Appendix354 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt02512
IRS990/AllOtherExpensesGrp/ProgramServicesAmt09489
IRS990/AllOtherExpensesGrp/TotalAmt012001
IRS990/BackupWthldComplianceInd0false
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd092657
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0980439
IRS990/CashNonInterestBearingGrp/EOYAmt0219428
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompDisqualPersonsGrp/FundraisingAmt08800
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt08800
IRS990/CompDisqualPersonsGrp/ProgramServicesAmt070400
IRS990/CompDisqualPersonsGrp/TotalAmt088000
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt024026
IRS990/CYOtherExpensesAmt0121640
IRS990/CYOtherRevenueAmt0-39029
IRS990/CYProgramServiceRevenueAmt0145199
IRS990/CYRevenuesLessExpensesAmt0-141907
IRS990/CYSalariesCompEmpBnftPaidAmt0150463
IRS990/CYTotalExpensesAmt0272103
IRS990/CYTotalFundraisingExpenseAmt09580
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0130196
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt047688
IRS990/DepreciationDepletionGrp/TotalAmt047688
IRS990/Desc0FOSTERING SCIENCE, RESEARCH AND TEACHING IN THE AREAS OF MEDICINE, BIOLOGY,CANCER AND AGING.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt02
IRS990/EmploymentTaxReturnsFiledInd0false
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0214158
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt03775
IRS990/FeesForServicesAccountingGrp/TotalAmt03775
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1SHILA ROOFIM
IRS990/Form990PartVIISectionAGrp/PersonNm2FOROUGH SOOFERIAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1CFO
IRS990/Form990PartVIISectionAGrp/TitleTxt2SEC
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/Form990TFiledInd0true
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt0-3589
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt068249
IRS990/GrossReceiptsAmt0331642
IRS990/GrossRentsGrp/RealAmt087801
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt02771
IRS990/InsuranceGrp/TotalAmt02771
IRS990/InvestmentIncomeGrp/ExclusionAmt027615
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt027615
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/EOYAmt068337
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt01132203
IRS990/LandBldgEquipBasisNetGrp/BOYAmt05876274
IRS990/LandBldgEquipBasisNetGrp/EOYAmt05774036
IRS990/LandBldgEquipCostOrOtherBssAmt06906239
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt071838
IRS990/LessRentalExpensesGrp/RealAmt0129608
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0154516
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0154516
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt09034148
IRS990/NetAssetsOrFundBalancesEOYAmt08892603
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt0-3589
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-3589
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt0-41807
IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt0-41807
IRS990/NetUnrlzdGainsLossesInvstAmt0362
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt09034148
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt08892603
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt046
IRS990/OfficeExpensesGrp/ProgramServicesAmt0117
IRS990/OfficeExpensesGrp/TotalAmt0163
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherExpensesGrp/Desc0PROPERTY TAX
IRS990/OtherExpensesGrp/Desc1UTILITIES
IRS990/OtherExpensesGrp/Desc2LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc3HOA DUES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt020446
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt115781
IRS990/OtherExpensesGrp/ProgramServicesAmt014150
IRS990/OtherExpensesGrp/ProgramServicesAmt13594
IRS990/OtherExpensesGrp/TotalAmt020446
IRS990/OtherExpensesGrp/TotalAmt115781
IRS990/OtherExpensesGrp/TotalAmt214150
IRS990/OtherExpensesGrp/TotalAmt33594
IRS990/OtherLiabilitiesGrp/BOYAmt033004
IRS990/OtherLiabilitiesGrp/EOYAmt021354
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0REWARDS
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt01271
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt01271
IRS990/OtherRevenueTotalAmt01271
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt050000
IRS990/OtherSalariesAndWagesGrp/TotalAmt050000
IRS990/PartialLiquidationInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt0780
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0780
IRS990/PayrollTaxesGrp/ProgramServicesAmt010903
IRS990/PayrollTaxesGrp/TotalAmt012463
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0541700
IRS990/ProgramServiceRevenueGrp/Desc0SUBSCRIPTION FEES
IRS990/ProgramServiceRevenueGrp/Desc1PRODUCTS
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0127543
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt117656
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0127543
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt117656
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt0-20244
IRS990/PYOtherExpensesAmt0130506
IRS990/PYOtherRevenueAmt020776
IRS990/PYProgramServiceRevenueAmt0286789
IRS990/PYRevenuesLessExpensesAmt05962
IRS990/PYSalariesCompEmpBnftPaidAmt0150853
IRS990/PYTotalExpensesAmt0281359
IRS990/PYTotalRevenueAmt0287321
IRS990/ReconcilationRevenueExpnssAmt0-141907
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/RentalIncomeOrLossGrp/RealAmt0-41807
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0145199
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt01507
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt01507
IRS990/SavingsAndTempCashInvstGrp/BOYAmt02364955
IRS990/SavingsAndTempCashInvstGrp/EOYAmt03006672
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt027615
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt08428
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt036043
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0147977
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0286789
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0434766
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt027615
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt08428
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt036043
IRS990ScheduleA/InvestmentIncomeCYPct00.07000
IRS990ScheduleA/InvestmentIncomePYPct00.03000
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus2YearsAmt017915
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt017915
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.88960
IRS990ScheduleA/PublicSupportPY509Pct00.91590
IRS990ScheduleA/PublicSupportTotal509Amt0434766
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0147977
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0286789
IRS990ScheduleA/Total509Grp/TotalAmt0434766
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0175592
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0295217
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt017915
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0488724
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt02519334
IRS990ScheduleD/BuildingsGrp/DepreciationAmt0769271
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt03288605
IRS990ScheduleD/LandGrp/BookValueAmt03229805
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt03229805
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt024897
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt0362932
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt0387829
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt016890
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt14464
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0TENANT DEPOSITS
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1CREDIT CARD/ PAYROLL TAXES
IRS990ScheduleD/TotalBookValueLandBuildingsAmt05774036
IRS990ScheduleD/TotalLiabilityAmt021354
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt0154516
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0TO AID THE ORGAN TO ACQUIRED INVEST
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0154000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0DIRECTOR
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/TotalBalanceDueAmt0154516
IRS990/ScheduleORequiredInd0false
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1SEE ATTACHMENT NOVEMBER 20, 2022 PART IV, LINE 63, LOANS FROM OFFICERS, DIRECTOR AND EMPLOYEE ON NOVEMBER 20, 2002, FRONTIERS IN BIOSCIENCE, INC. PURCHASED FOR INVESTMENT PURPOSES ONLY RESIDENTIAL REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NEW YORK. IN CONNECTION WITH THE ORGANIZATION'S PURCHASE OF SAID REAL ESTATE, FRONTIERS IN BIOSCIENCE INC., INCURRED A MORTGAGE PAYABLE WITH THE PRESIDEN AND FOUNDER, SIAMAK TABIBZADEH, MD, IN THE AMOUNT OF 145,000 LENDER'S NAME: SIAMAK TABIBZADEH, MD ORIGINAL AMOUNT OF NOTE: 154,000 BALANCE DUE: 145,555 DATE OF NOTE: NOVEMBER 20, 2002 MATURITY DATE: OPEN, SEE BELOW REPAYMENT TERMS: PRINCIPAL AND ACCRUED INTEREST DUE UPON SALE OF PROPERTY INTEREST RETE: RATE OF 4.5% PER ANNUM, PRINCIPAL AND INTEREST DUE UPON SALE OF PROPERTY OR AT SUCH TIME AS THE BOARD OF DIRECTOR DETERMINES THAT THERE ARE SUFFICIENT OPERATING FUNDS TO RETIRE THE OBILIGATION SECURITY PRIOVIDED BY THE BORROWER: MORTGAGE NOTE SECURED BY REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NY 11507 PURPOSE OF THE LOAN: TO BE ABLE TO PURCHASE REAL ESTATE AT BELOW FAIR MARKET VALUE TO SEE IN NO LONGER THAN TWO OPERATING CYCLES IN ORDER TO OBTAIN SUFFICIENT FUNDING TO ENDOW A FULL TIME MEDICAL RESEARCHER AND EDITOR. INTERST CALCUATION ORIGINAL AMOUNT OF PRINCIPAL: 154,000 FROM TO INTEREST AMOUNT (RATE, 4.5%) - PRINCIPAL + INTEREST NOV 20, 2002 154,000 NOV 20, 2002 NOV 20, 2003 6,930 - 160,930 - 15,375 REMOVED PRINCIPAL & INTEREST LEAVING 145,555 NOV 20, 2003 NOV 20, 2004 6,549 - 152,104 NOV 20, 2004 NOV 20, 2005 6,844 - 158,948 NOV 20, 2005 NOV 20, 2006 7,152 - 166,100 NOV 20, 2006 NOV 20, 2007 7,474 - 173,574 NOV 20, 2007 NOV 20, 2008 7,810 - 181,384 NOV 20, 2008 NOV 20, 2009 8,162 - 189,546 NOV 20, 2009 NOV 20, 2010 8,529 - 198,075 NOV 20, 2010 NOV 20, 2011 8,913 - 206,988 NOV 20, 2011 NOV 20, 2012 9,314 - 216,302 NOV 20, 2012 NOV 20, 2013 9,733 - 226,035 NOV 20, 2013 NOV 20, 2014 10,171 - 236,206 NOV 20, 2014 NOV 20, 2015 10,629 - 257,942 NOV 20, 2015 NOV 20, 2016 11,107 - 246,835 NOV 20, 2016 NOV 20, 2017 11,607 - 269,549 PRINCIPAL PAID 269,549-145,555=123,994 NOV 20, 2017 NOV 20, 2018 5,579 - 129,573 NOV 20, 2018 NOV 20, 2019 5,830 - 135,403 NOV 20, 2019 NOV 20, 2020 6,093 - 141,496 NOV 20, 2020 NOV 20, 2021 6,367 - 147,863 NOV 20, 2021 NOV 20, 2022 6,653 - 154.516
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2NO REVIEW WAS OR WILL BE CONDUCTED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NO DOCUMENTS AVAILABLE TO THE PUBLIC
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4ADJUSTMENT TO BEGINNING OF VALUE OF INVESTMENTS -14160
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART XI
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt09221668
IRS990/TotalAssetsEOYAmt09068473
IRS990/TotalAssetsGrp/BOYAmt09221668
IRS990/TotalAssetsGrp/EOYAmt09068473
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt02
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt09580
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt048365
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0214158
IRS990/TotalFunctionalExpensesGrp/TotalAmt0272103
IRS990/TotalGrossUBIAmt0-41807
IRS990/TotalLiabilitiesBOYAmt0187520
IRS990/TotalLiabilitiesEOYAmt0175870
IRS990/TotalLiabilitiesGrp/BOYAmt0187520
IRS990/TotalLiabilitiesGrp/EOYAmt0175870
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt09034148
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt08892603
IRS990/TotalProgramServiceExpensesAmt0214158
IRS990/TotalProgramServiceRevenueAmt0145199
IRS990/TotalRevenueGrp/ExclusionAmt027615
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0144388
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0130196
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt0-41807
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt09221668
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt09068473
IRS990/TravelGrp/ProgramServicesAmt01271
IRS990/TravelGrp/TotalAmt01271
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0true
IRS990/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/USAddress/CityNm0NEWPORT COAST
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd092657
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0WWW.BIOSCIENCE.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0SIAMAK TABIBZADEH MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum09497158286
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-05-03
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0FRONTIERS IN BIOSCIENCE
ReturnHeader/Filer/BusinessNameControlTxt0FRON
ReturnHeader/Filer/EIN0593432665
ReturnHeader/Filer/PhoneNum09497158286
ReturnHeader/Filer/USAddress/AddressLine1Txt020 SUNSET COVE
ReturnHeader/Filer/USAddress/CityNm0NEWPORT COAST
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092657
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330990695
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0LGH CONSULTING INC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0585 S STATE COLLEGE BLVD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ANAHEIM
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0928064222
ReturnHeader/PreparerPersonGrp/PhoneNum07148089170
ReturnHeader/PreparerPersonGrp/PreparationDt02023-05-05
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0GEORGE HUKRIEDE
ReturnHeader/ReturnTs02023-05-05T14:06:19-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0SIAMAK
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0TABIBZADEH
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$9,068,473
Liabilities
$175,870
Net assets
$8,892,603
Revenue
$130,196
Expenses
$272,103
Net income
-$141,907
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022Detailed filing. Detailed filing data is available for this year.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.94$0.04$7.90$0.88$0.56$0.32
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30